Nortrel21 Day (Teva Pharmaceuticals USA, Inc.)


Welcome to the PulseAid listing for the Nortrel drug offered from Teva Pharmaceuticals USA, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Pharmaceuticals USA, Inc.
NON-PROPRIETARY NAME: Norethindrone and Ethinyl Estradiol
SUBSTANCE NAME: NORETHINDRONE; ETHINYL ESTRADIOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2001-06-13
END MARKETING DATE: 0000-00-00


Nortrel 21 Day HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNortrel 21 Day from Teva Pharmaceuticals USA, Inc.
LABELER NAME: Teva Pharmaceuticals USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1; .035(mg/1; mg/1)
START MARKETING DATE: 2001-06-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0555-9009_3ca5a20b-8b30-4ed8-b668-617b250e41fc
PRODUCT NDC: 0555-9009
APPLICATION NUMBER: ANDA072693

Other NORETHINDRONE; ETHINYL ESTRADIOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Teva Pharmaceuticals USA, Inc.Nortrel